CompletedPhase 2NCT01701999
Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid
Studying Botulism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- California Department of Public Health
- Principal Investigator
- Stephen S. Arnon, M.D.California Department of Public Health
- Intervention
- rBV A/B(biological)
- Enrollment
- 45 enrolled
- Eligibility
- 18-69 years · All sexes
- Timeline
- 2013 – 2015
Study locations (2)
- California Department of Public Health, Richmond, California, United States
- Battelle Biomedical Research Center, West Jefferson, Ohio, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01701999 on ClinicalTrials.govOther trials for Botulism
Additional recruiting or active studies for the same condition.